Swell Conversations

Swell Conversations is a promotional podcast series exploring expert perspectives on hereditary angioedema (HAE), including disease-management approaches. Each episode is moderated by John Anderson, MD, clinical assistant professor at The University of Alabama at Birmingham and partner at AllerVie Health, and features national HAE experts who provide commentary on a variety of HAE topics and share their personal insights. Topics include connecting with patients on the science of HAE, highlighting emerging research in the management of patients with normal, functional levels of C1 inhibitor, sharing strategies to engage your patients in conversations about intravenous self-administration, and discussing redosing and its possible impact on patients. These conversations will include a discussion of RUCONEST® (C1 esterase inhibitor [recombinant]), an on-demand treatment option for adult and adolescent patients with HAE.

Recent Episodes

View all
Assessing Contributors to Anxiety: The Unpredictability of HAE
6
July 10, 2025

Assessing Contributors to Anxiety: The Unpredictability of HAE

Join us for an engaging discussion on potential contributors to patient anxiety related to hereditary angioedema (HAE). Our expert moderator, John Anderson, MD, clinical assistant professor at The University of Alabama at Birmingham and partner at AllerVie Health/AllerVie Clinical Research, welcomes Kimberly Poarch, PA-C, from Allergy & Asthma Specialists of Dallas. She will share emerging reports on factors impacting anxiety among patients with HAE and explore strategies to engage with patients
Listen to the Episode
Managing HAE Attacks: Patient Behavior and the Decision to Treat
5
May 21, 2025

Managing HAE Attacks: Patient Behavior and the Decision to Treat

Welcome back to Swell Conversations: A Promotional HAE Series ! John Anderson, MD, clinical assistant professor at The University of Alabama at Birmingham and partner at AllerVie Health, returns to chat with Andrew Smith, MD, MS, owner and physician at Allergy Associates of Utah, about emerging topics in the management of hereditary angioedema (HAE). This episode explores the decision-making patterns of patients who are considering the use of an on-demand HAE treatment and examines practical app
Listen to the Episode
Bridging the Conversation: Redosing in HAE
4
Feb. 8, 2024

Bridging the Conversation: Redosing in HAE

In our final episode, hereditary angioedema (HAE) treatment redosing takes center stage during a discussion with Dr. John Anderson, clinical assistant professor at The University of Alabama at Birmingham and partner at AllerVie Health, and Dr. Raffi Tachdjian, associate clinical professor at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Drs. Anderson and Tachdjian will define redosing and explore misconceptions about redosing with acute HAE treatments.
Listen to the Episode
Instilling IV Confidence: Self-Administration in HAE
3
Jan. 11, 2024

Instilling IV Confidence: Self-Administration in HAE

We’re back with John Anderson, MD, clinical assistant professor at The University of Alabama at Birmingham and partner at AllerVie Health, and Shahnaz Fatteh, MD, physician at the Asthma, Allergy Care Center of Florida, as they address clinician questions around intravenous (IV) self-administration within the context of RUCONEST® (C1 esterase inhibitor [recombinant]). RUCONEST can be administered via IV self-administration and is indicated to treat acute attacks in adult and adolescent patients
Listen to the Episode
Painting the Picture: HAE Types and Management Approaches
2
Dec. 8, 2023

Painting the Picture: HAE Types and Management Approaches

Today on “Swell Conversations: A Promotional HAE Series,” John Anderson, MD, clinical assistant professor at The University of Alabama at Birmingham and partner at AllerVie Health, welcomes Douglas H. Jones, MD, practicing physician at the Tanner Clinic in Layton, Utah. In this episode, they break down the three types of hereditary angioedema (HAE) and share their personal approaches to disease management. Special attention is given to exploring HAE when C1 inhibitor (C1-INH) levels and function
Listen to the Episode
Simplifying the Science: The Root Cause of HAE
1
Nov. 13, 2023

Simplifying the Science: The Root Cause of HAE

Join esteemed experts John Anderson, MD, clinical assistant professor at The University of Alabama at Birmingham and Partner at AllerVie Health, and Dareen D. Siri, MD, chief executive officer and physician at Midwest Allergy Sinus Asthma, SC in Illinois, as they explore how and why hereditary angioedema (HAE) occurs, including the multifaceted role of C1 inhibitor. They will also provide their clinical perspectives on connecting with patients and engaging ways to communicate the HAE disease mec
Listen to the Episode
View all Episodes